Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PharmacoEconomics - open

Showing results (21-30 of 653) with videos related to

Pageof 66
Sort By:
Pharmacoeconomics - Open|August 27, 2025
Willingness to Pay for Improved Quality of Services from Informal Health Providers in Urban Slums in NigeriaObinna Onwujekwe, Godwin Uche Ezema, Chukwudi Nwokolo, et al.
Pharmacoeconomics - Open|April 16, 2020
Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive BladderGreta Lozano-Ortega, Carol R Schermer, David R Walker, et al.
Pharmacoeconomics - Open|May 9, 2021
Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot StudyDavid J Mott, Iain Leslie, Koonal Shah, et al.
Pharmacoeconomics - Open|February 3, 2023
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)Owen Alan Edwards Cooper, Ola Ghatnekar, Natalia Piglowska, et al.
Pharmacoeconomics - Open|April 4, 2017
The Potential Cost-Effectiveness of HIV Vaccines: A Systematic ReviewBlythe Adamson, Dobromir Dimitrov, Beth Devine, et al.
Pharmacoeconomics - Open|October 18, 2022
Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB)Meryl Brod, Michael Højby Rasmussen, Suzanne Alolga, et al.
Pharmacoeconomics - Open|July 25, 2019
Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes MellitusMargarita Capel, Andreea Ciudin, María Mareque, et al.
Pharmacoeconomics - Open|July 21, 2019
Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree AnalysisPaola Rucci, Vera Maria Avaldi, Claudio Travaglini, et al.
Pharmacoeconomics - Open|July 23, 2019
All Male Panels and Other Diversity Considerations for ISPORNancy J Devlin
Pharmacoeconomics - Open|March 4, 2021
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?Giancarlo Pruneri, Filippo De Braud, Anna Sapino, et al.
Pageof 66

Showing results (21-30 of 653) with videos related to

Sort By:
Pageof 66
Pharmacoeconomics - Open|August 27, 2025
Willingness to Pay for Improved Quality of Services from Informal Health Providers in Urban Slums in NigeriaObinna Onwujekwe, Godwin Uche Ezema, Chukwudi Nwokolo, et al.
Pharmacoeconomics - Open|April 16, 2020
Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive BladderGreta Lozano-Ortega, Carol R Schermer, David R Walker, et al.
Pharmacoeconomics - Open|May 9, 2021
Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot StudyDavid J Mott, Iain Leslie, Koonal Shah, et al.
Pharmacoeconomics - Open|February 3, 2023
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)Owen Alan Edwards Cooper, Ola Ghatnekar, Natalia Piglowska, et al.
Pharmacoeconomics - Open|April 4, 2017
The Potential Cost-Effectiveness of HIV Vaccines: A Systematic ReviewBlythe Adamson, Dobromir Dimitrov, Beth Devine, et al.
Pharmacoeconomics - Open|October 18, 2022
Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB)Meryl Brod, Michael Højby Rasmussen, Suzanne Alolga, et al.
Pharmacoeconomics - Open|July 25, 2019
Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes MellitusMargarita Capel, Andreea Ciudin, María Mareque, et al.
Pharmacoeconomics - Open|July 21, 2019
Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree AnalysisPaola Rucci, Vera Maria Avaldi, Claudio Travaglini, et al.
Pharmacoeconomics - Open|July 23, 2019
All Male Panels and Other Diversity Considerations for ISPORNancy J Devlin
Pharmacoeconomics - Open|March 4, 2021
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?Giancarlo Pruneri, Filippo De Braud, Anna Sapino, et al.
Pageof 66